O’Melveny Adds Pharma IP Litigator Gregory Morris in New York

Gregory Morris has joined O’Melveny as a partner in its intellectual property and technology practice group in New York, the law firm announced Monday.

Morris focuses on pharmaceutical, biotechnology, and medical technology patent litigation, according to the firm.

He joins the firm from Honigman in Chicago, where he established the firm’s life science IP litigation practice, O’Melveny said.

This story was produced by Bloomberg Law Automation.